Nation and world news briefs
1 in 3 Americans would refuse COVID-19 vaccine, new Gallup poll findsOne in 3 Americans would refuse an FDA-approved coronavirus vaccine even if it were offered at no cost, a new Gallup poll released Friday found.The results, based on survey conducted between July 20 and Aug. 2, found that 65% of respondents said they would accept the offer and get themselves vaccinated while 35% said they would not.The new poll falls in line with previous Gallup findings suggesting political party preference plays a strong role in Americans’ views on COVID-19.Eighty-one% of Democrats would be willing to get v...
Tribune News Service
In search for COVID-19 treatments, consumer group pushes drugmaker Gilead to test alternative to remdesivir
The pharmaceutical company that makes remdesivir — the only medication that has emergency authorization to fight COVID-19 — should also be conducting human trials on a related drug with strong potential, according to a citizen advocacy group that believes the alternative could be more effective, less expensive and easier to produce.Washington, D.C.-based Public Citizen sent a letter dated Tuesday to the CEO of Gilead Sciences and top federal regulators, urging the company and the government to work together to move forward with clinical trials of the drug “or publicly provide evidence why it i...
Study: Antiviral drug remdesivir helps white, Black and Latino patients equally
CHICAGO — Remdesivir, the only drug given emergency approval for treatment of COVID-19, appears to provide equal benefits to white, Asian, Black and Latino patients, according to an analysis led by researchers at University of Chicago Medicine.It’s encouraging news, infectious disease experts say, because of the disparate effects of the disease on different groups. Black people are dying at higher rates than people of other races, and Latinos are contracting the disease at higher rates than others.Dr. Kathleen Mullane, a UChicago Medicine infectious disease expert, said the results — which wer...
Florida sees 6,336 additional coronavirus cases, pushing total past 206,000
MIAMI — Florida’s Department of Health on Monday confirmed 6,336 additional cases of COVID-19, bringing the state’s total to 206,447. There were also 47 new deaths announced, raising the statewide death toll to 3,778.There were no new non-resident deaths announced, keeping the statewide non-resident death total at 101.The state began adding antigen test results to Florida’s case totals on Thursday. Antigen tests are a new category of tests that detect fragments of proteins found in the virus by testing samples collected by nose swabs. The Food and Drug Administration authorized the first antig...
Hydroxychloroquine is the most disappointing, disavowed drug that researchers keep studying for COVID-19
Barely three months ago, the anti-malarial drug that President Donald Trump touted seemed like such a sure bet against COVID-19 that Susanna Naggie had a tough time setting up a national clinical trial comparing it to placebo. Colleagues said giving a fake pill would be unethical since the real thing might save lives.Now, hydroxychloroquine, or HCQ, has fallen into such disfavor that healthcare workers are leery of Naggie’s trial. Called HERO (a loose acronym for HEalth Care Worker pROphylaxis Against COVID-19) it is designed to see if the drug can protect them from infection.“Our original rec...
The Philadelphia Inquirer
Moderna delays Phase 3 trial for COVID-19 vaccine
Moderna’s heavily anticipated trial for a coronavirus vaccine, which was set to begin next week, has been delayed.“Moderna has previously disclosed that the Phase 3 trial of its COVID-19 vaccine candidate mRNA-1273 is expected to begin in July. The trial is still expected to begin in July and we expect to be the first to start a Phase 3 trial,” read a company statement sent to The New York Daily News Thursday. “We have worked closely with NIH/OWS to align on the final protocol in order to begin the trial on time.”The Phase 3 study, which includes 30,000 patients, was initially supposed to begi...
New York Daily News
3 dead in New Mexico after drinking hand sanitizer, 4th permanently blinded
Three people in New Mexico have died and a fourth is permanently blind after drinking a dangerous amount of hand sanitizer, officials said.The state’s Department of Health on Friday said another three patients remained in critical condition over the weekend. All seven people “are believed to have drunk hand sanitizer containing methanol,” it said.Swallowing methanol, when it isn’t lethal, can cause brain damage, blindness as well as nerve and kidney damageWhile authorities have not provided specific details they suspect the string of poisonings are related to alcoholism. It’s not uncommon for ...
New York Daily News
Small turnout expected this week as St. Louis Blues begin Phase 2 workouts
ST. LOUIS — For the first time in more than three months, St. Louis Blues players will be on the ice at Centene Community Ice Center as the team formally begins Phase 2 of the NHL’s return-to-play plan Monday. Phase 2 consists of small-group individual workouts, and in the case of the Blues — the emphasis is on the “small.”General manager Doug Armstrong said only three players are scheduled to skate at Centene this week. Since the Phase 2 program is voluntary, Armstrong declined to mention their names.As for the rest of the squad, Armstrong said: “Most of our guys are skating with bigger group...
St. Louis Post-Dispatch
Commentary: On a doctor's right to try in the age of COVID-19
Should doctors who are working in COVID-19 intensive care units have access for themselves to Moderna’s potential coronavirus vaccine? U.S. health care workers are infected with the virus every day. If we have a probable vaccine that is almost certainly reasonably safe and likely to be effective, why shouldn’t doctors — who are scientifically trained to make these judgments — be allowed to vaccinate themselves to protect both their own lives and those they treat?Yes, it’s possible that there will be unacceptable side effects. Like other medicines, a COVID-19 vaccine may be right for some peopl...
Tribune News Service
Illumina launches first COVID-19 test based on next-generation gene sequencing
SAN DIEGO — Illumina has won regulatory approval for the first COVID-19 based on next- generation gene sequencing, which could help track mutations of the virus while delivering high-volume results.The U.S. Food and Drug Administration approved an Emergency Use Authorization on Tuesday for Ilumina’s coronavirus test. It can deliver results in 24 hours from nasal or throat swabs.Called COVIDSeq, Illumina’s high volume test includes 98 DNA or RNA markers that target the full SARS-CoV-2 genome. The test is currently available on a limited basis but will become more broadly available this summer.A...
The San Diego Union-Tribune